2Suppliers
2Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Ovid Therapeutics Inc. (OVID) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships
2Distinct source URLs
4High confidence
0.810Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Ovid Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
LGND Ligand Pharmaceuticals Incorporated 72% Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGND graph: tia”) in September 2023) in 2017, Ovid Therapeutics Inc. (“Ovid”) in October…
LGNZZ LGNZZ 72% Reciprocal relationship from LGNZZ graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGNZ…

Ovid Therapeutics Inc. Customers

TickerNameConfidenceEvidence
LGND Ligand Pharmaceuticals Incorporated 72% Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: ndensed consolidated balance sheets…
LGND Ligand Pharmaceuticals Incorporated 72% ndensed consolidated balance sheets. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arisi…

Ovid Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
OVID-DEBT-11627 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
OVID-DEBT-59802 Warrants outstanding: 1.09 90% xbrl warrant detail from xbrl 2026-03-31.
OVID-DEBT Debt stack $13.1M 90% Market cache reports total debt of $13.1M.

Ovid Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ovid Therapeutics Inc..

Ovid Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
OVID-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 104 tracked holders.

Ovid Therapeutics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LONA LeonaBio, Inc. 100.00 2
CRMD CorMedix Inc. 100.00 2
SGMO Sangamo Therapeutics, Inc. 100.00 2
VKTX Viking Therapeutics, Inc. 100.00 2
AGEN Agenus Inc. 100.00 2
PLX Protalix BioTherapeutics, Inc. 100.00 2
LGND Ligand Pharmaceuticals Incorporated 100.00 1 ['customer', 'supplier']
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
ELUT Elutia Inc. 100.00 2
LGNZZ LIGAND PHARMACEUTICALS INC 100.00 1 ['supplier']
BSX Boston Scientific Corporation 50.00 2
DNTH Dianthus Therapeutics, Inc. 50.00 2
CURX Curanex Pharmaceuticals Inc 50.00 2
ANEB Anebulo Pharmaceuticals, Inc. 50.00 2
JJETF BARCLAYS BANK PLC 50.00 2
OABIW OmniAb, Inc. 50.00 2
PTHS Pelthos Therapeutics Inc. 50.00 2
XOMA XOMA Royalty Corporation 50.00 2
XOMAP XOMA Royalty Corporation 50.00 2
RYLAZE RYLAZE 23.09 2
🔐
OVID
Unlock OVID Supply Chain Data
Verified relationships include:
LGNDLigand Pharmaceuticals In…Supplier72%
LGNZZLGNZZSupplier72%
LGNDLigand Pharmaceuticals In…Customer72%
LGNDLigand Pharmaceuticals In…Customer72%
+4 more relationships locked
Subscribe, View plans →